At the IGTP TODAY

News

The European Innovation Council provides €3 million in funding for a project with IGTP involvement

The European Commission has granted €2,999,101 in funding to the NanoBiCar project, coordinated by Universitat Politècnica de València, with the participation of the Germans Trias i Pujol Research Institute (IGTP). The grant falls within the EIC Pathfinder Program of the European Innovation Council (EIC), a highly competitive program aimed at identifying, developing, and scaling up breakthrough technologies and disruptive innovations.

IGTP and DevsHealth join forces to develop new antibiotics against hospital-acquired infections by multi-resistant Staphylococcus aureus

DevsHealth, a leading company in artificial intelligence (AI) driven drug discovery, and the Germans Trias i Pujol Research Institute (IGTP), a public research centre in biomedical sciences, have announced a new partnership to develop new antibiotics for multi-resistant Staphylococcus aureus infections.

- Innovation, Research

Progress in developing specific immunotherapies for type 1 diabetes

Researchers from IGTP and Ahead Therapeutics have been exploring a treatment based on liposome-type nanoparticles to address the autoimmunity of type 1 diabetes for years. A study recently published in the Journal of Autoimmunity examines the response of macrophages to this immunotherapy, serving as a preliminary step before clinical trials.

Innomed programme kicks off

The Innomed programme has been launched with the ambition of transforming the landscape of health innovation at the Can Ruti Campus, creating synergies between the public and private sectors. With a structured approach around three key axes - nurturing the culture of innovation, fostering project incubation, and facilitating cross-sector collaboration - Innomed aims to turn knowledge into action to achieve tangible impact on the healthcare community.